Skip to main content
Clinical Trials/ACTRN12615000737538
ACTRN12615000737538
Terminated
未知

Is intermittent Theta Burst Stimulation (iTBS) Transcranial Magnetic Stimulation (TMS) helpful in treatment of Body Dysmorphic Disorder (BDD) in people who do not respond to currently available treatments?

St Vincent’s Hospital, Melbourne.0 sites10 target enrollmentJuly 17, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
St Vincent’s Hospital, Melbourne.
Enrollment
10
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 17, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St Vincent’s Hospital, Melbourne.

Eligibility Criteria

Inclusion Criteria

  • 18\-65 years.
  • DSM\-5 criteria for BDD, and clinical psychiatric evaluation.
  • Treatment refractoriness: no response or insufficient response following at least 2 treatments with a selective serotonin reuptake inhibitor (SSRI) at maximum dosage for at least 12 weeks, plus at least 1 Cognitive\-Behavioural Therapy (CBT) trial for a minimum of 16 sessions (Phillips, 2008\).
  • 20 or higher on the BDD version on the Yale\-Brown Obsessive Compulsive Scale for Body Dysmorphic Disorder (BDD YBOCS).

Exclusion Criteria

  • Active substance abuse, neurological disorder including a history of seizures or epilepsy, pregnancy, or any current medical disorder that may affect cerebral metabolism; or acutel suicidality.
  • Also: cochlear implants; metallic implants in the brain or elsewhere (splinters, clips, fragments); an implanted neurostimulator (deep brain stimulator, vagal nerve stimulator, epidural/subdural stimulator); cardiac pacemaker or intracardiac line; or medication infusion device.

Outcomes

Primary Outcomes

Not specified

Similar Trials